Sort   by:  
 Page size 
UnknownPhysiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants.
Not available
S-EPMC8138939 | biostudies-literature
UnknownTissue Oxygenation Changes After Transfusion and Outcomes in Preterm Infants: A Secondary Near-Infrared Spectroscopy Study of the Transfusion of Prematures Randomized Clinical Trial (TOP NIRS).
Not available
S-EPMC10514737 | biostudies-literature
UnknownHigher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants.
Not available
S-EPMC8487591 | biostudies-literature
UnknownExtended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical Trial.
Not available
S-EPMC12038711 | biostudies-literature
UnknownMortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018.
Not available
S-EPMC8767441 | biostudies-literature
UnknownTiming of Red Blood Cell Transfusions and Occurrence of Necrotizing Enterocolitis: A Secondary Analysis of a Randomized Clinical Trial.
Not available
S-EPMC11069076 | biostudies-literature
UnknownHydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.
Not available
S-EPMC9107291 | biostudies-literature
UnknownHeterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial.
Not available
S-EPMC10233424 | biostudies-literature
UnknownAssessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Not available
S-EPMC10167571 | biostudies-literature
UnknownSocial Determinants of Health and Redirection of Care for Infants Born Extremely Preterm.
Not available
S-EPMC10928542 | biostudies-literature
Sort   by:  
 Page size